Showing results (71-80 of 190) with videos related to

Sort By:
Pageof 19
Antimicrobial Agents and Chemotherapy|January 30, 1999
Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureusJ R Aeschlimann, L D Dresser, G W Kaatz, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1997
Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection modelM J Rybak, H H Houlihan, R C Mercier, et al.
Clinical Pharmacokinetics|September 1, 1988
Inhibition of drug metabolism by quinolone antibioticsD J Edwards, S K Bowles, C K Svensson, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1992
Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremiaM J Rybak, E M Bailey, K C Lamp, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1992
Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection modelB J McGrath, E M Bailey, K C Lamp, et al.
Pharmacotherapy|April 30, 1999
Outcome assessment of minimizing vancomycin monitoring and dosing adjustmentsC M Karam, P S McKinnon, M M Neuhauser, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1995
Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection modelD M Cappelletty, S L Kang, S M Palmer, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1996
Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release from Escherichia coli and Pseudomonas aeruginosaK C Lamp, M J Rybak, B J McGrath, et al.
DICP : the Annals of Pharmacotherapy|July 1, 1991
Vancomycin protein binding in patients with infections caused by Staphylococcus aureusL M Albrecht, M J Rybak, L H Warbasse, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1994
Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditisB J McGrath, S L Kang, G W Kaatz, et al.
Pageof 19